Companies › Caris Life Sciences

Caris Life Sciences

Company Pharma & Medical Devices

Caris Life Sciences is listed as a company in Pharma & Medical Devices. It has filed 3 comment letters on 2 proposed federal rules between 2025 and 2026, most often with the Office of the Secretary.

Type
Company
Industry
Pharma & Medical Devices
Comment letters
3
Rules commented on
2
First letter
2025-03-14
Latest letter
2026-09-01
Agencies most often
Office of the Secretary (2); Centers for Medicare & Medicaid Services (1)

Activity by year

20252
20261

Letters

2026

Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; and Quality Reporting Programs; Including the Hospital Outpatient Quality Reporting Program and Ambulatory Surgical Center Quality Program; Request for Information on Strengthening the Standardization and Comparability of Hospital Price Transparency (HPT) Data; Prior Authorization; Accrediting Organization (AO) Deeming for Emergency Medical Treatment and Labor Act (EMTALA); and Notices of Closure of Teaching Hospitals and Opportunities To Apply for Available Slots

CMS-2026-2344Health and Human Services Department, Centers for Medicare & Medicaid Services · filed 2026-09-01

2025

HIPAA Security Rule To Strengthen the Cybersecurity of Electronic Protected Health Information

HHS-OCR-2024-0020Health and Human Services Department, Office of the Secretary · filed 2025-03-14

HIPAA Security Rule To Strengthen the Cybersecurity of Electronic Protected Health Information

HHS-OCR-2024-0020Health and Human Services Department, Office of the Secretary · filed 2025-03-14